Welcome to our dedicated page for Allied Motion SEC filings (Ticker: ALNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allient Inc. (Nasdaq: ALNT) SEC filings page on Stock Titan is intended to bring together the company’s regulatory disclosures once they are available from the U.S. Securities and Exchange Commission’s EDGAR system. Allient is a global engineering and manufacturing enterprise that develops precision and specialty Motion, Controls and Power products and solutions for targeted industries and applications, including medical, life sciences, aerospace and defense, industrial automation, robotics, semiconductor, transportation, agriculture, construction and facility infrastructure.
For a company with this profile, core SEC filings such as annual reports on Form 10‑K and quarterly reports on Form 10‑Q typically provide detailed information on segment performance across markets like Industrial, Medical, Vehicle, and Aerospace & Defense, as well as discussions of demand drivers such as power quality solutions for HVAC and data center infrastructure, defense and space program deliveries, and selected medical applications. Other filings, including Form 8‑K, often summarize earnings releases, dividend declarations, strategic initiatives and significant events affecting the business.
As these documents become available, Stock Titan’s platform can surface them alongside AI‑powered summaries that explain key points in accessible language. This can help readers quickly interpret disclosures related to revenue trends, gross margin and operating margin commentary, cash flow, leverage ratios, and management’s discussion of macro factors such as tariff developments and rare earth material trade constraints. For those monitoring governance and ownership, forms related to insider activity, such as Form 4, and proxy materials on Schedule 14A are also relevant.
Although no specific SEC filings are listed in the current data set, this page is designed to update as new Allient filings are posted to EDGAR. Users can then review the full text of each filing together with AI‑generated highlights to better understand how Allient’s Motion, Controls and Power technologies, financial performance, capital structure and risk factors are described in its official regulatory reports.
Winter Michael R reported acquisition or exercise transactions in this Form 4 filing.
ALLIENT INC director Michael R. Winter received a grant of 374 shares of Common Stock as part of his quarterly retainer. The award was made on March 5, 2026 under the company’s Non-Employee Director Compensation Policy and 2017 Omnibus Incentive Plan at a price of $62.07 per share.
After this equity grant, he directly holds 39,341 shares of Allient common stock. In addition, he has an indirect holding of 847 shares through an individual 401(k) plan, reflecting retirement-related ownership separate from his direct stake.
Tzetzo Nicole R reported acquisition or exercise transactions in this Form 4 filing.
ALLIENT INC director Nicole R. Tzetzo received a grant of 374 shares of common stock as part of her quarterly retainer on the company’s 2017 Omnibus Incentive Plan. The award on March 5, 2026 was recorded at $62.07 per share and increased her directly held shares to 14,232.
The filing also reports 600 shares held indirectly through a general partnership associated with her spouse. She disclaims beneficial ownership of those indirectly held shares except to the extent of her spouse’s pecuniary interest.
Finch Steven C. reported acquisition or exercise transactions in this Form 4 filing.
ALLIENT INC director Steven C. Finch received an award of 374 shares of common stock on March 5, 2026. The shares were granted as part of his quarterly retainer under the company’s Non-Employee Director Compensation Policy within the 2017 Omnibus Incentive Plan at a price reference of $62.07 per share.
After this grant, Finch directly holds a total of 13,005 shares of Allient common stock. This reflects equity-based compensation rather than an open-market purchase or sale.
Federico Richard D reported acquisition or exercise transactions in this Form 4 filing.
ALLIENT INC director Richard D. Federico received an equity grant of 433 shares of Common Stock as part of his quarterly retainer. The award was made on March 5, 2026 under the company’s Non-Employee Director Compensation Policy and 2017 Omnibus Incentive Plan. After this grant, he directly owns 76,563 shares of Allient common stock.
Engel Robert B reported acquisition or exercise transactions in this Form 4 filing.
Allient Inc. director Robert B. Engel received a grant of 374 shares of common stock as part of his quarterly retainer. The shares were valued at $62.07 per share and were awarded under the Company’s Non-Employee Director Compensation Policy and 2017 Omnibus Incentive Plan. After this grant, Engel directly owns 32,237 Allient common shares.
Warzala Stephen reported acquisition or exercise transactions in this Form 4 filing.
ALLIENT INC executive Stephen Warzala, VP and Group President, reported equity awards of common stock as part of his compensation. He received 1,664 time-based restricted shares that vest one-third each on April 1, 2027, 2028 and 2029. He was also granted 1,189 performance-based restricted shares that may vest over three years if performance goals for the year ending December 31, 2026 are met, and 345 performance-based restricted shares that were earned based on 2025 goals and vest one-third each on April 1, 2026, 2027 and 2028. Following these awards, his directly held common stock increased in stages to 36,028 shares, with additional indirect holdings reported through various trusts and an ESOP trust.
May Kenneth Arthur reported acquisition or exercise transactions in this Form 4 filing.
Allient Inc. Chief Technology Officer Kenneth Arthur May reported equity awards of common stock on March 5, 2026. He received 1,048 time-based restricted shares at $62.07 per share that vest in three equal parts on April 1 of 2027, 2028 and 2029.
He was also granted 838 performance-based restricted shares that may vest over a three-year period based on goals set for the year ending December 31, 2026, and 285 performance-based restricted shares that were earned on goals for 2025 and vest one-third each on April 1 of 2026, 2027 and 2028. The filing also shows 1,228 shares held indirectly through an ESOP trust.
ALLIENT INC reported that VP and Group President Helmut Pirthauer acquired 1,552 shares of common stock through a grant of time-based restricted shares under the company’s 2017 Omnibus Incentive Plan at $62.07 per share. Total direct holdings increased to 46,053 shares after this award.
The restricted shares vest in three equal installments, with one-third scheduled to vest on April 1, 2027, one-third on April 1, 2028, and the final third on April 1, 2029, aligning the executive’s compensation with longer-term company performance.
ALLIENT INC VP and Group President Ashish Bendre reported equity awards of company stock. On March 5, 2026, he acquired a total of 3,032 shares of common stock as stock grants valued at
The awards include time-based restricted shares that vest in three equal parts on
ALLIENT INC Chief Financial Officer James A. Michaud reported multiple share awards of common stock on March 5, 2026. The Form 4 shows three acquisitions of shares as grants or awards, rather than open‑market purchases.
One grant consists of time‑based restricted shares awarded under the Company’s 2017 Omnibus Incentive Plan, vesting one‑third each on April 1, 2027, 2028 and 2029. Additional performance‑based restricted share grants were reported, which will vest over a three‑year period if specified performance goals for the year ending December 31, 2026 are met. A further performance‑based award was earned based on goals for the year ended December 31, 2025 and will vest one‑third each on April 1, 2026, 2027 and 2028.